Literature DB >> 11023663

Soluble CD40 ligand induces beta-chemokine production by macrophages and resistance to HIV-1 entry.

P di Marzio1, R Mariani, R Lui, E K Thomas, N R Landau.   

Abstract

CD40 ligand (CD40L) is a cell surface molecule of CD4(+)T cells that interacts with its receptor CD40 on antigen presenting cells to mediate thymus-dependent humoral immunity and inflammatory reactions. We report here that treating monocyte-derived macrophages (MDM) with a trimeric soluble form of CD40L (CD40LT) induced them to secrete high levels of the beta-chemokines RANTES, MIP-1alpha and MIP-1beta that are ligands for CCR5 and able to inhibit HIV-1 entry. CD40LT inhibited the entry of M-tropic HIV-1 reporter viruses. Furthermore, supernatants obtained from CD40LT-stimulated macrophages protected CEMx174-CCR5 cells from infection by HIV-1(JRFL)reporter virus. The inhibitory activity appeared to be due to beta-chemokines present in the supernatant, since pretreating them with a cocktail of antibodies to RANTES, MIP-1alpha and MIP-1beta neutralized the inhibitory activity of the supernatants. In addition, treating monocytes with CD40LT caused CCR5 and CD4 to be downregulated from the cell surface. In vivo, macrophages activated through CD40 could interfere with HIV replication. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023663     DOI: 10.1006/cyto.1999.0594

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

Review 1.  Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infection.

Authors:  Nikolaos V Sipsas; Petros P Sfikakis
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

2.  Expression of CD154 by a simian immunodeficiency virus vector induces only transitory changes in rhesus macaques.

Authors:  Vida L Hodara; M Cristina Velasquillo; Laura M Parodi; Luis D Giavedoni
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Levels of soluble CD40 ligand (CD154) in serum are increased in human immunodeficiency virus type 1-infected patients and correlate with CD4(+) T-cell counts.

Authors:  Nikolaos V Sipsas; Petros P Sfikakis; Athanasios Kontos; Theodore Kordossis
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Aggregation-independent modulation of proteoglycan binding by neutralization of C-terminal acidic residues in the chemokine macrophage inflammatory protein 1alpha.

Authors:  K Ottersbach; G J Graham
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

5.  A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia.

Authors:  Qiusheng Si; Melissa Cosenza; Mee-Ohk Kim; Meng-Liang Zhao; Michael Brownlee; Harris Goldstein; Sunhee Lee
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

Review 6.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

7.  Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates.

Authors:  Theresa L Chang; Arielle Klepper; Jian Ding; John Garber; Aprille Rapista; Arevik Mosoian; Wolfgang Hubner; Julio Gutierrez; Jose Walewski; Jeffrey Abergel; Thomas Schiano; Andrea Branch
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.